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Abstract: A mathematical correlation of the MLCT absorption
maxima of structurally related fac-[M(CO)3L2Br] complexes (M =
Mn, Re; L2 = bidentate ligand) is obtained by the comparison
of a total of 50 species bearing bipyridine, pyridinylpyrazine,
azopyridine and pyridin-2-ylmethanimine L2 type ligands. The
empirical relationship is first derived by the initial comparison
of the MLCT absorption maxima of 26 previously published
complexes and subsequently used to predict the same absorp-
tion value of 24 other species. In order to check the validity of
the prediction, several new complexes were prepared. These
were spectroscopically characterized and, where possible, their
X-ray solid-state structure elucidated. The initial mathematical
Introduction
CO-releasing molecules (CORMs) are an established class of
compounds that exploit the now well-known cytoprotective
and homeostatic properties of carbon monoxide for medical
applications. A challenge in the development of such molecules
resides in the fact that the starting time of action of the mole-
cules can be particularly difficult to influence. Methods to initi-
ate controlled CO release rely on enzymatic,[1] electromagnetic
heating,[2] pH and oxidation-dependent activation.[3] Light trig-
gered release of CO is another convenient approach to work
with CORMs because of the on-off feedback control it offers.
When light is employed for the activation of these pro-drugs,
the compounds are consensually referred as photoCORMs and
undoubtedly fac-[Mn(CO)3]+-based photoCORMs are the most
commonly encountered in the scientific literature. The vast ma-
jority of photoCORMs is activated with wavelengths in the UV
region of the electromagnetic spectrum but a shift towards the
red region is desirable to achieve deeper skin penetration (e.g.
for sub-cutaneous applications of the molecules) and to avoid
the dangerous effects of UV light on living tissues.[4]
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correlation allowed to predict MLCT absorption maxima of the
unknown species with an average discrepancy of 12 nm. The
relationship was subsequently refined to an average error of
6 nm with following derived formula CalcMnMLCT = (ObsReMLCT/
0.88) – 15.1 (where CalcMnMLCT = predicted values of Mn com-
plexes MLCT and ObsReMLCT = experimentally observed MLCT
transitions of Re complexes). The correlation and the formula,
the significance of which are discussed, may prove useful in
the long run for the rational design of Mn-based photoCORMs
starting from known data of widely investigated fac-
[Re(CO)3L2Br] complexes.
It remains however, very difficult to predict the wavelength
of photo activation of new fac-[Mn(CO)3]+-based photoCORMs.
In fact, visible and infrared light-activated photoCORMs repre-
sent to date only a small fraction of all reported molecules.[5]
The conceptual chemical framework for the synthesis of these
species relies on modifications of the inner- and outer-coordina-
tion sphere of the metal ion in such a way as to finely tune the
energy gap of the orbitals involved in the lowest energy elec-
tronic transition.[6] This is almost invariably a MLCT transition
involving a HOMO of predominantly metal character and a
LUMO mainly localized on the aromatic bidentate ligand (most
often a polypyridyl ligand). This electronic transition has the
crucial effect of reducing metal to ligand π-backbonding, hence
destabilizing the M–CO bond, and leading to the liberation of
CO in its gaseous form.
These chemical approaches enabled several authors to real-
ize fac-[Mn(CO)3]+-based photoCORMs with red-shifted MLCT
transitions. Moreover, similar effects have been obtained by ap-
plying the same strategy to the corresponding Re derivatives,
although in such cases it was observed that the presence of a
strong MLCT transition in the visible region of the electromag-
netic spectrum is not a sufficient prerequisite to activate fac-
[Re(CO)3]+-based photoCORMs towards CO release. While some
examples have been reported,[7] the number of Re-based pho-
toCORMs is marginal compared to the Mn-based ones. This dif-
ference is understood in terms of spin-orbit coupling (promi-
nent in heavy metals) which promotes intersystem crossing to
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the triplet 3MLCT state in Re species thus stabilizing the M–CO
bond.[8] Nevertheless, complexes of the fac-[Re(CO)3]+ core are
extensively investigated for their use in e.g. catalysis,[9] imag-
ing,[10] or cancer therapy,[11] and a large body of spectroscopic
data is available in literature.
Given the structural and electronic similarities of fac-
[M(CO)3]+ complexes of Re and Mn and the wealth of spectro-
scopic information of Re species, we wondered if the latter
could not be exploited as a blueprint for the rational design of
tri-carbonyl Mn-based photoCORMs. Relative effects of first row
vs. third row transition metal ions in CO photorelease were par-
tially discussed before[12] and it was shown by DFT calculations
that the same orbitals are involved in the MLCT transition of
equivalent complexes of the two metal ions.[6b,13] The differ-
ence being in the energy separation of the orbitals which, as
expected, is greater for Re. With this theoretical basis, the start-
ing hypothesis of this investigation was to assume that fac-
[Re(CO)3L2Br] complexes behave spectroscopically in a related
fashion to the analogous fac-[Mn(CO)3L2Br] species with the
same bidentate L2 ligand in identical conditions. This assump-
tion is corroborated not only by logical chemical intuition but
empirically also by a survey of the literature data.[6a,6b,13,14] Em-
pirical correlations of electrochemical[15] and vibrational[16] pa-
rameters of Mn and Re complexes have been already reported.
However, mathematical models correlating the light absorption
properties for this class of complexes have never been estab-
lished. Such a model could play an important role in the ra-
tional design of new photoCORMs. Moreover, since Re com-
plexes are usually more stable than their Mn counterparts, the
application of this model would simplify the synthetic efforts.
In fact, the possibility of predicting a priori the MLCT transition
of the target molecules is certainly an advantage for the ra-
tional design of photoCORMs.
In this contribution we have precisely investigated this possi-
bility and we show that a mathematical correlation of the MLCT
absorption maxima of structurally related fac-[M(CO)3L2Br] com-
plexes (M = Mn, Re; L2 = bidentate ligand) can be derived from
the comparison of these species. The empirical mathematical
relationship described in the following pages was first derived
by the comparison of previously published complexes and sub-
sequently used to predict the same absorption value of other
species. To check the validity of the prediction several new
complexes were prepared and are herein reported. The signifi-
cance of the correlation is finally discussed.
Results and Discussion
Data Selection and First Correlation
In order to gather enough data for a statistically significant
comparison, we began our study with a literature research of
structurally related fac-[M(CO)3L2Br] complexes (M = Mn, Re;
L2 = bidentate ligand). We restricted our selection to pairs of
complexes with identical coordination spheres and (where pos-
sible) whose MLCT absorption maxima were tabulated. It is
worth to mention that the determination of MLCT transition is
not always trivial, particularly for Re species whose MLCT bands
often appear as shoulders of the stronger ligand π–π* transi-
tions. This initial search led to the selection of thirteen pairs
of Re- and Mn-based compounds (1–26, Figure 1). The MLCT
absorption maxima of these species are given in Table 1 and
Figure 1. Molecular structures of species 1–26. M = fac-[M(CO)3Br] with either
Mn or Re.
Table 1. MLCT absorption maxima of complexes 1–26.
Mn species MLCT [nm] Re species MLCT [nm] Δ [nm][h]
1[14] 430[a] 2[14] 370[a] 60
3[17] 420[c] 4[18] 380[d] 40
5[14] 430[a] 6[14] 370[b] 60
7[19] 426[d] 8[19] 375[d] 51
9[19] 430[d] 10[19] 388[d] 42
11[20] 430[a] 12[14] 375[b] 55
13[21] 495[c] 14[22] 452[c] 43
508[g] 464[g] 44
15[22] 452[e] 16[22] 418[e] 34
473[g] 430[g] 43
17[22] 497[e] 18[22] 450[e] 47
517[g] 465[g] 52
19[17] 460[a] 2036 415[b] 45
21[23] 452[c] 22[24] 396[f ] 56
23[25] 485[c] 24[24] 435[c] 50
25[13] 586[d] 26[13] 530[d] 56
[a] CH2Cl2. [b] DMF. [c] THF. [d] CH3CN. [e] CHCl3. [f ] Butyronitrile, and [g]
Toluene as solvent. [h] Δ = MnMLCT – ReMLCT.
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Figure 2. Plot of observed MLCT absorption maxima of fac-[Mn(CO)3L2Br]
complexes against the same value of the corresponding fac-[Re(CO)3L2Br]
complexes (species 1–26). Red line = linear fitting (R2 = 0.96); green lines =
95 % confidence interval; blue lines = 95 % prediction interval.
plotted in Figure 2. According to the best linear fit through the
16 points plotted in Figure 2, the following equation is derived
for the MLCT correlation of fac-[M(CO)3L2Br] complexes:
ObsReMLCT [nm] = (0.98 ± 0.05) ObsMnMLCT [nm] – (37.4 ± 26.0)
(R2 = 0.96)
(where ObsReMLCT and ObsMnMLCT = experimentally observed
MLCT transitions of Re and Mn complexes, in nm). UV/Visible
absorption spectra are largely dependent on the medium in
which they are recorded and solvatochromic effects are ex-
pected to influence the correlation. Unfortunately, for each pair
of compounds different authors report data in different sol-
vents. No correction was made to account for variables like the
pH, polarity, dielectric constants, or viscosity of the medium.
The analysis shows that the MLCT absorption maxima of four
pair of complexes (1/2, 5/6, 15/16 measured in CHCl3 and 23/
24) are outside the 95 % confidence interval (CI). Because CI is
a type of interval estimate that might contain the true value of
an unknown population parameter, we excluded these points
and recalculated the equation above: Equation (1).
ObsReMLCT [nm] = (0.94 ± 0.04) ObsMnMLCT [nm] – (17.4 ± 18.0)
(R2 = 0.98) (1)
Some scattering is observed particularly in the more ener-
getic transitions of complexes bearing bipyridine type ligands
but the correlation between observed MLCT absorption max-
ima of structurally related fac-[M(CO)3L2Br] complexes shows a
good linearity, as proved by the value of R2 parameter which is
very close to the unit (R2 = 0.98).
Having established a first correlation between the MLCT ab-
sorption maxima of related fac-[M(CO)3L2Br] complexes, we pro-
ceeded to its validation and refinement. To this end, we sought
to predict via Equation (1) the MLCT absorption values of
a) species that were not included in the initial correlation and
b) previously unknown complexes. Six Re complexes (30–38
and 46, Figure 3) were then synthesized in order to compare
them with corresponding Mn compounds published in litera-
ture. For the same reason, Mn complex 39 was also prepared
along with molecule pairs 41–44 and 47–50 (Figure 3). Finally
complex 28, previously published by the group of Alberto,[14]
was resynthesized in order to obtain its electronic UV/Visible
spectrum in the same solvent of the corresponding Mn species
published by our group.[6a]
Figure 3. Molecular structures of species 27–50. M = fac-[M(CO)3Br] with ei-
ther Mn or Re; Φ = phenyl.
Synthesis and Characterization
Re complexes 30–38 and 42–50 were prepared by reaction of
the [Et4N]2fac-[Re(CO)3Br3] salt with the relevant L2 ligands
which were in turn prepared according to reported procedures
(see experimental section for details). All new species were
characterized via standard techniques and their purity con-
firmed via elemental analysis. 1H-NMR spectra showed pure dia-
magnetic compounds, according to the symmetry given by the
facially arranged COs and low-spin d6 nature of the metal ion.
IR spectroscopy analysis was in accordance with the typical tri-
carbonyl vibration pattern. Of this complex series, crystals suit-
able for X-ray diffraction analysis were obtained for eight spe-
cies. Crystallographic details are presented in Table 2, spectro-
scopic data are listed in Table 3 while structural parameters are
given in the Supporting Information.
3
htt
p:/
/do
c.r
ero
.ch
Table 2. Crystallographic details for complexes 32, 34, 36, 38, 44, 46, 49, and 50.
32 34 36 38 44 46 49 50
Formula C17H14BrN2O3ReS C17H14BrN2O4ReS C22H15BrFN2O3ReS C20H14BrN2O3ReS C24H12Br2N4O6Re2 C14H6BrN2O4Re C15H12BrMnN2O4 C15H12BrN2O4Re
MW 592.48 608.48 672.54 628.51 984.60 532.32 419.11 550.38
T [K] 250(2) 250(2) 250(2) 250(2) 200(2) 293(2) 250(2) 250(2)
Lattice triclinic triclinic monoclinic monoclinic monoclinic monoclinic monoclinic triclinic
Space group P1 P1 P21/n P21/n C2/c P21/n P21/n P1
Z 2 2 4 4 4 4 4 2
a [Å] 7.6734(5) 7.7208(10) 7.9346(4) 10.0632(4) 17.6909(8) 6.5359(7) 9.0940(5) 7.9055(10)
b [Å] 7.7388(5) 7.8806(10) 21.9827(11) 11.6027(3) 24.7765(7) 16.7815(19) 15.1304(9) 8.3868(10)
c [Å] 17.3622(12) 17.915(2) 12.5942(6) 17.3107(8) 6.8265(2) 13.2352(16) 11.5589(7) 12.1769(17)
α [°] 83.703(5) 87.252(10) 90 90 90 90 90 93.574(9)
 [°] 86.496(6) 79.557(10) 96.199(4) 99.629(4) 99.689(4) 100.162(9) 99.670(5) 93.489(10)
γ [°] 65.608(5) 63.761(9) 90 90 90 90 90 90.658(10)
V [Å3] 933.183 960.875 2183.89 1992.73 2949.5 1428.89 1567.86 804.19
dcalcd [g/cm3] 2.109 2.103 2.045 2.095 2.217 2.474 1.776 2.273
R1, wR2 0.0237, 0.0593 0.0193, 0.0415 0.032, 0.0732 0.0219, 0.0500 0.0419, 0.1266 0.1298, 0.3060 0.0397, 0.1093 0.0793, 0.2600
Table 3. MLCT absorption maxima[a] of complexes 27–50.
Mn species MLCT [nm] MLCT [nm] Δ [nm][c] Re species MLCT [nm] MLCT [nm] Δ [nm][c]
observed predicted[b] observed predicted[b]
27[6a] 630 626.0 4.0 28[14] 571 574.8 3.8
29[6a] 678 667.4 10.6 30 610 619.9 9.9
31[26a] 488 460.0 28.0 32 415 441.3 26.3
33[26a] 498 491.9 6.1 34 445 450.7 5.7
35[26a] 497 495.1 1.9 36 448 449.8 1.8
37[26b] 535 529.1 5.9 38 480 485.5 5.5
39 430 444.0 14.0 40[14] 400 386.8 13.2
41 512 529.1 17.1 42 480 463.9 16.1
43 573 596.2 23.2 44 543 521.2 21.8
45[20] 430 444.0 14.0 46 400 386.8 13.2
47 463 472.8 9.8 48 427 417.8 9.2
49 407 416.4 9.4 50 374 365.2 8.8
[a] CH2Cl2 as solvent. [b] According to Equation (1). [c] Δ = IMMLCTpred. – MMLCTobs.I.
Figure 4. X-ray structures of: (top) species 32 (left) and 34; (bottom) 36 (left) and 38. Thermal ellipsoids set at a 30 % probability level. Hydrogen atoms are
omitted for clarity.
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Figure 5. X-ray structures of (top) species 44 (left) and 46, and (bottom) 49 (left) and 50. Thermal ellipsoids set at a 30 % probability level. Hydrogen atoms
are omitted for clarity.
Complexes 32 and 34 crystallized in a triclinic lattice and
space group P1 whereas 36 and 38 were obtained in the mono-
clinic space group P21/n (Figure 4). The four complexes present
a distorted octahedral geometry with structural parameters
similar to those of the analogous Mn-based complex.[26] Crys-
tals of 44 were obtained by slow evaporation of an acetone
solution (Figure 5). The molecule crystallized in a monoclinic
lattice in the space group C2/c. As predicted, two metallic cen-
ters are connected homotopically to each binding site of the
ligand. Each fac-[Re(CO)3]+ unit is coordinated to both the pyr-
imidine and pyrazine sites of the ligands with one bromide ion
as ancillary ligand. Crystals of compound 46, 49 and 50 suitable
for X-ray diffraction measurements were obtained by pentane
diffusion into a CH2Cl2 solution (Figure 5). Complex 46 crystal-
lized in the monoclinic space group P21/n, whereas compounds
49 and 50 in the monoclinic space group P21/n and in the
triclinic space group P1 respectively. The complexes exhibit a
slightly distorted octahedral geometry but are not significantly
different from the corresponding manganese complexes previ-
ously described.[20,27]
UV/Visible Electronic Spectroscopy and Correlation
Validation and Refinement
Table 3 lists spectroscopic data of compounds 27–50 while Fig-
ure 6 shows selected absorption spectra of the same com-
plexes. Mn species typically show MLCT bands at a wavelength
of 430, 500–550 and 630 nm for complexes bearing bipyridines,
pyridin-2-ylmethanimines and azopyridines respectively. For the
corresponding Re complexes the wavelength required for same
transitions is 30–50 nm higher. In order to validate the correla-
tion shown in Figure 2, the measured MLCT absorption maxima
Figure 6. Selected absorption spectra of representative fac-[M(CO)3L2Br] com-
plexes (M = Mn, top, M = Re, bottom) investigated in this study.
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of a set of species of one of the metal congeners (e.g. Mn) were
used to predict the position of the same transition for the other
set of metal (e.g. Re) complexes according to Equation (1).
Thus, the MLCT absorption maxima of each metal ion were
calculated starting from the observed absorbance of the corre-
sponding congener (i.e. by using observed ReMLCT to predict
MnMLCT and vice versa). The results of this analysis are shown
in Figure 7 where ObsMMLCT and CalcMMLCT absorption maxima
for each metal ion are plotted. According to the fit through the
12 points plotted in Figure 7, ObsMMLCT and CalcMMLCT positions
correlate linearly with R2 values of 0.97.
Figure 7. Plot of observed vs. predicted MLCT absorption maxima of fac-
[M(CO)3L2Br] complexes (M = Mn, top, R2 = 0.97; M = Re, bottom, R2 = 0.97)
according to Equation (1). Predicted MLCT absorption maxima for each metal
ion were calculated starting from the observed absorbance values of the
corresponding congener (i.e. using observed ReMLCT to predict MnMLCT and
vice versa). Red lines = linear fits; green lines = 95 % confidence interval; blue
lines = 95 % prediction interval.
In both cases (i.e. whether predicting via (1) Mn values from
Re data or vice versa) an average discrepancy of 12 nm is calcu-
lated between ObsMMLCT and CalcMMLCT. The pair of complexes
31/32 and 43/44 (see Figure 3) lay out of line and the confi-
dence interval, with a difference > 21 nm between the ob-
served and predicted values. The former are complexes bearing
a pyridin-2-ylmethanimines ligand. Lumsden has shown that
such compounds (with Mn as central metal ion) undergo speci-
ation in solution as a consequence of the thioether group re-
placing a cis CO ligand and thereby altering the coordination
sphere of the metal center and the wavelength of the MLCT
band.[26a] We believe, however, that it is rather unlikely that the
same type of ligand substitution (i.e. CO replacement) takes
place in stable fac-[Re(CO)3Br] species. In fact, we found no such
evidence via IR or NMR spectroscopy. The latter couple (i.e. 43/
44) is the only dimeric set of the entire 50 complexes series we
have analyzed. Here perhaps electronic coupling between the
metal centers may influence the metal-centered HOMO or li-
gand-centered LUMO energies to an extent not observable in
mononuclear complexes. If these points are omitted, ObsMMLCT
and CalcMMLCT positions correlate linearly with R2 values of 0.99.
Having established the possibility of predicting via Equa-
tion (1) MLCT absorption values of species which were not in-
cluded in the initial correlation, the latter was refined by includ-
ing all 44 complexes in the analysis (i.e. 25–3 pair of complexes
out of CI). Equation (1) was thus recalculated to:
ObsReMLCT [nm] = (0.89 ± 0.02) ObsMnMLCT [nm] + (7.8 ± 11.2)
(R2 = 0.99) (2)
Equation (2) was subsequently used to derive CalcMnMLCT
from tabulated ObsReMLCT absorption maxima and the former
Figure 8. Top: plot of observed MLCT absorption maxima of fac-[Mn(CO)3L2Br]
complexes against the same value of corresponding fac-[Re(CO)3L2Br] com-
plexes (22 pairs of complexes, R2 = 0.99). Bottom: plot of observed vs. pre-
dicted [according to Equation (4)] MLCT absorption maxima of fac-
[Mn(CO)3L2Br] complexes (22 pairs of complexes, R2 = 0.99). Red lines = linear
fits; green lines = 95 % confidence interval; blue lines = 95 % prediction inter-
val.
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than the experimentally observed ObsMnMLCT data. The analysis
gave:
ObsMnMLCT [nm] = (0.99 ± 0.03) CalcMnMLCT [nm] + (6.2 ± 12.4)
(R2 = 0.99) (3)
Finally, ObsMnMLCT from Equation (3) was substituted in
Equation (2) in order to directly relate experimentally observed
MLCT transitions of Re complexes (i.e. ObsReMLCT) to CalcMnMLCT.
The linear regression between the scalar dependent CalcMnMLCT
variable and the independent ObsReMLCT variable finally gave
the following relationship:
CalcMnMLCT [nm] = (ObsReMLCT [nm]/0.88 ± 0.06) – 13.3 ± 17.9
(R2 = 0.99) (4)
With Equation (4) the average discrepancy between
CalcMnMLCT and ObsMnMLCT was further reduced to 6 nm (i.e.
CalcMnMLCT = ObsMnMLCT ± 6 nm). Plots of this analysis are
shown in Figure 8. All points calculated with (4) fall within the
statistical 95 % prediction interval.
Significance of the Correlation
As mentioned in the introduction, the study described above
was intended to derive a mathematical tool for the rational
design of Mn-based photoCORMs starting from known spectro-
scopic data of widely investigated fac-[Re(CO)3L2Br] complexes.
With Equation (4) this is now possible within an acceptable mar-
gin of error. Beyond the potential practical aspects of this study,
some theoretical considerations may be discussed. MLCTs ana-
lyzed in this study involve formally excitation of an electron
from a HOMO of predominantly metal character to a LUMO of
predominantly L2 ligand character. As such, the wavelength of
MLCTs can be taken as a measure of the relative energy separa-
tion between the two orbitals (i.e. the HOMO-LUMO gap). The
energetic separation between the HOMO and the LUMO is obvi-
ously greater for the third row Re ion and it originates funda-
mentally from: a) the greater radial extension of Re 5d orbitals
(as compared to Mn 3d orbitals) which interact more strongly
with L2 ligand orbitals, b) the energetic separation ΔE between
donor and acceptor atomic orbitals involved in bonding, and
c) the overlap integral S between the two orbitals (and thus the
metal-ligand bond length). There is clearly a strong interplay
among the three factors in determining the final MO orbital
energies. Given that we have compared fac-[M(CO)3L2Br] com-
plexes with identical coordination spheres, the atomic orbital
energies of the ligands can be considered as a constant, thus
the HOMO-LUMO gap (and the energy associated with the
MLCT wavelength) may be taken as dependent only of the
metal atomic orbital energies. For our discussion, we will con-
sider calculated orbital energies for the neutral metal atoms.
These depend strongly on the configuration used to calculate
the ground state, but since both metal ions analyzed are low
spin d6 ions our assumption should give a coherent picture. If
one considers only calculated orbital energies for the neutral
metal atoms it is interesting to note that the 0.89 value of the
slope correlating MnMLCT and ReMLCT is approximately the
same factor relating metal d-orbital energies for the neutral
metal atoms (i.e. –12.05 eV and –10.62 eV for Mn and Re respec-
tively; 10.62/12.05 = 0.88).[28] We finally note in passing that
theoretically one should be able to correlate MLCT energies
with the electrochemical[15] (EL) and infrared[16] (IRP) parameters
previously described (both of which are a measure of the elec-
tronic density on the central metal ion on octahedral com-
plexes). In particular, given that MLCTs formally involve oxid-
ation of the metal ion and reduction of the of L2 ligand, a linear
correlation should be observed with the EL parameters. Unfortu-
nately, the limited number of ligands parametrized in the two
models, and common to the study herein described does not
permit to establish a quantitative correlation of our model with
electrochemical and vibrational data.
Conclusions
Facial tricarbonyl Mn(I) species are known as photoactivatable
CO releasing molecules (photoCORM). As a starting base for
the rational design of Mn-based photoCORMs, a mathematical
correlation of the MLCT absorption maxima of structurally re-
lated fac-[M(CO)3L2Br] complexes (M = Mn, Re; L2 = bidentate
ligand) was described in order to tentatively predict the MLCT
absorption energies of manganese complexes from measured
MLCT absorption maxima of analogous rhenium compounds
with identical coordination ligand-spheres. The empirical rela-
tionship was determined for fac-[M(CO)3L2Br] species coordi-
nated by bipyridine, pyridinylpyrazine, azopyridine and pyridin-
2-ylmethanimine L2 type ligands. To archive a statistically signif-
icant correlation, a total of 25 pairs of complexes were analyzed
including several new complexes which were prepared to check
the validity of the prediction. Formula (4) allows predicting
MLCT absorption maxima of unknown Mn species with an aver-
age error of 6 nm. The correlation shows relatively high disper-
sion for points < 425 nm, thus one may tentatively posit the
assumption that the correlation is valid mostly for compounds
with MLCTs in the visible light region of the spectrum. While it
is clear that the design of potentially valuable photoCORM can-
not be reduced to a simple MLCT transition position, we believe
that the possibility of predicting a priori specific characteristics
of the molecules (i.e. in this case the wavelength of photo-
activation) constitutes an important tool for the design of pho-
toCORMs. Equation (4) may thus prove useful in the field as a
guide for a preliminary check to evaluate if efforts directed to-
wards synthesis of a new type of potential photoCORMs with
specific required wavelengths of CO activation may be valuable
or not, also in view of the higher stability of Re complexes with
respect to their Mn analogues.
Experimental Section
Data Selection: The literature was searched for a large representa-
tive number of structurally identical complexes of the type fac-
[M(CO)3L2L′] (M = Mn, Re) with the metal ion in a d6 configuration.
Both monomeric and dimeric species with mono- (L′) and bidentate
(L2) ligands were included in the pool. MLCT data were selected as
reported by the authors and no solvent correction was applied to
the reported values. Statistical analysis of confidence and prediction
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intervals of the parameters were performed according to the proce-
dure described by Bewik et al.[29] The Excel program (2016) was
used to setup formula for statistical analysis and derive equations
for the best linear fits. The Origin program (version 7.5) was used
to plot data.
General Experimental Details: All chemicals and reagents were
purchased from standard commercial sources, stored in accordance
to the indications provided by the supplier and used as received.
All the reactions, purifications and solution analysis involving Mn(I)
species were carried out in the absence of light. Solid IR spectra
were recorded on a Bruker Tensor 27 instrument. ESI-MS were re-
corded on a Bruker esquire HCT spectrometer, with methanol as
solvent. 1H-NMR were recorded on Bruker Avance III spectrometers
operating at 400 or 500 MHz (as specified for each molecule). The
corresponding 1H shifts are reported relative to residual solvent pro-
tons. UV/Vis spectroscopy was performed using a Jasco V-730 spec-
trophotometer and data treated with the SpectraManager software.
The λmax of the MLCT transitions of newly synthesized complexes
were chosen by calculating the first derivative of the absorption
curve and selecting the numerical value where the derivative is
0. Elemental analyses (EA) were performed on a Leco CHNS-932
elemental analyzer. Single crystal diffraction collections were done
on Stoe IPDS2 diffractometer (MoKα1 (λ = 0.71073 Å)) equipped
with a cryostat from Oxford Cryosystems. The structure were solved
with the ShelXT structure solution program[30] using Intrinsic Phas-
ing and refined with the ShelXL refinement package[31] using least-
squares minimization.
CCDC 1877322 (for 34), 1877323 (for 32), 1877324 (for 36), 1877325
(for 46), 1877326 (for 44), 1877327 (for 38), 1877422 (for 49), and
1877423 (for 50) contain the supplementary crystallographic data
for this paper. These data can be obtained free of charge from The
Cambridge Crystallographic Data Centre.
Synthesis of Ligands and Metal Complexes
fac-[Re(CO)3L2Br] L2 = (1,2-Bis(4-(trifluoromethyl)pyridin-2-yl)-
diazene) (30): The L2 ligand was prepared according to litera-
ture.[6a] A total of 39 mg (0.05 mmol) of [Et4N]2 fac-[Re(CO)3Br3]
were dissolved in 10 mL of H2O. Then, 20 mg (0.06 mmol, 1.1 equiv.)
of L2 in 1 mL of ethanol were added dropwise under nitrogen. The
reaction mixture was then stirred at room temperature for 4 h under
nitrogen, until a green precipitate was formed. The compound was
filtered, and a purified by column chromatography (SiO2) using
CH2Cl2/MeOH + NH3 10 % 98:2 as eluent. The expected compound
was the first blue product to elute. The fraction was collected, dried
and analyzed. Yield: 13 mg (27 %). Elemental Anal. Calcd. for
C15H6BrF6N4O3Re: C 26.88 %, H 0.90 %, N 8.36 %. Found: C 27.03 %,
H 1.00 %, N 8.97 %. 1H-NMR (500 MHz, CD2Cl2): δ (ppm) = 7.94–7.90
(m, 2H), 8.62 (s, 1H), 9.00 (s, 1H), 9.03 (d, J = 5.14 Hz, 1H), 9.35 (d,
J = 5.80 Hz, 1H). IR (KBr pellet): νC≡O = 2032 cm–1, 1923 cm–1. MLCT
band (CH2Cl2) [ε (M–1 cm–1)]: 610 nm (4459). ESI-MS analysis (posi-
tive mode) m/z = 591.1 [M – Br]+.
Complexes 32–36 and their respective ligands L2 were prepared
according to the procedure described in literature[26a] for the equiv-
alent Mn complexes with small variations. Generally: the [Et4N]2 fac-
[Re(CO)3Br3] salt and the L2 ligand were dissolved in separate CH2Cl2
solutions. L2 was then added dropwise under nitrogen to the Re
solution. The reaction mixture was then stirred under nitrogen at
room temperature overnight. At the end of the reaction, pentane
was carefully layered on top of the solution and the mixture was
allowed to stand until crystals of 32–36 appeared. These were then
filtered, dried and analysed. Single crystals suitable for X-ray diffrac-
tion analysis were grown by slow diffusion of pentane into a CH2Cl2
solution of the complex.
fac-[Re(CO)3L2Br] L2 = (N-((6-Methylpyridin-2-yl)methylene)-2-
(methylthio)aniline) (32): 219 mg (0.284 mmol) of [Et4N]2 fac-
[Re(CO)3Br3] in 10 mL of CH2Cl2; 67 mg (0.275 mmol, 0.9 equiv.) of
L2 in 10 mL of CH2Cl2. Yield: 98 mg (58 %). Elemental Anal. Calcd.
for C17H14BrN2O3ReS: C 34.46 %, H 2.38 %, N 4.73 %. Found:
C 34.55 %, H 2.42 %, N 4.70 %. 1H-NMR (400 MHz, CD2Cl2): δ
(ppm) = 2.53 (s, 3H), 3.06 (s, 3H), 7.32 (t, J = 7.58 Hz, 1H), 7.39 (t,
J = 7.58 Hz, 1H), 7.45 (d, J = 7.95 Hz, 1H), 7.64 (d, J = 7.95 Hz, 1H),
7.67 (d, J = 7.66 Hz, 1H), 7.83 (d, J = 7.65 Hz, 1H), 7.97 (t, J = 7.66 Hz,
1H), 8.75 (s, 1H). IR (KBr pellet): νC≡O = 2014 cm–1, 1881 cm–1. MLCT
band (CH2Cl2) [ε (M–1 cm–1)]: 413 nm (1865). ESI-MS analysis (posi-
tive mode) m/z = 513.1 [M – Br]+.
fac-[Re(CO)3L2Br] L2 = (N-((6-Methoxypyridin-2-yl)methylene)-2-
(methylthio)aniline) (34): 219 mg (0.284 mmol) of [Et4N]2 fac-
[Re(CO)3Br3] in 10 mL of CH2Cl2; 71 mg (0.275 mmol, 0.9 equiv.) of
L2 in 10 mL of CH2Cl2. Yield: 87 mg (50 %). Elemental Anal. Calcd.
for C17H14BrN2O4ReS: C 33.56 %, H 2.32 %, N 4.60 %. Found: C
33.98 %, H 2.36 %, N 4.51 %. 1H-NMR (400 MHz, CD2Cl2): δ (ppm) =
2.51 (s, 3H), 4.19 (s, 3H), 7.18 (d, J = 8.63 Hz, 1H), 7.31 (t, J = 7.55 Hz,
1H), 7.37 (dt, J = 7.62 Hz, 1H), 7.44 (d, J = 7.92 Hz, 1H), 7.65 (d, J =
7.38 Hz, 1H), 7.69 (d, J = 7.76 Hz, 1H), 8.08 (t, J = 8.02 Hz, 1H), 8.72
(s, 1H). IR (KBr pellet): νC≡O = 2014 cm–1, 1877 cm–1. MLCT band
(CH2Cl2) [ε (M–1 cm–1)]: 445 nm (2272). ESI-MS analysis (positive
mode) m/z = 528.9 [M – Br]+.
fac-[Re(CO)3L2Br] L2 = (N-((6-(4-Fluorophenyl)pyridin-2-yl)meth-
ylene)-2-(methylthio)aniline) (36): 219 mg (0.284 mmol) of [Et4N]2
fac-[Re(CO)3Br3] in 10 mL of CH2Cl2; 88 mg (0.275 mmol, 0.9 equiv.)
of L2 in 10 mL of CH2Cl2. Yield: 119 mg (62 %). Elemental Anal.
Calcd. for C22H15BrFN2O3ReS: C 39.29 %, H 2.25 %, N 4.17 %. Found:
C 38.30 %, H 2.26 %, N 4.01 %. 1H-NMR (400 MHz, CD2Cl2): δ
(ppm) = 2.54 (s, 3H), 7.26–7.33 (m, 4H), 7.39 (t, J = 7.61 Hz, 1H), 7.45
(d, J = 8.03 Hz, 1H), 7.62 (d, J = 7.72 Hz, 2H), 7.73 (d, J = 7.85 Hz,
1H), 8.05 (d, J = 7.61 Hz, 1H), 8.15 (t, J = 7.71 Hz, 1H), 8.96 (s, 1H).
IR (KBr pellet): νC≡O = 2019 cm–1, 1934 cm–1, 1897 cm–1. MLCT band
(CH2Cl2) [ε (M–1 cm–1)]: 390 nm (1336). ESI-MS analysis (positive
mode) m/z = 593.1 [M – Br]+.
fac-[Re(CO)3L2Br] L2 = (2-(Methylthio)-N-(quinolin-2-ylmethyl-
ene)aniline) (38): The L2 ligand was prepared according to litera-
ture.[26b] 219 mg (0.284 mmol) of [Et4N]2 fac-[Re(CO)3Br3] in 10 mL
of CH2Cl2; 76 mg (0.275 mmol, 0.9 equiv.) of L2 in 10 mL of CH2Cl2.
Yield: 93 mg (52 %). Elemental Anal. Calcd. for C20H14BrN2O3ReS: C
38.22 %, H 2.25 %, N 4.46 %. Found: C 37.86 %, H 2.29 %, N 4.13 %.
1H-NMR (400 MHz, CD2Cl2): δ (ppm) = 2.54 (s, 3H), 7.36 (t, J =
7.55 Hz, 1H), 7.43 (t, J =8.27 Hz, 1H), 7.48 (d, J = 7.91, 1H), 7.72 (d,
J = 7.82 Hz, 1H), 7.90 (t, J = 8.06 Hz, 1H), 8.07–8.11 (m, 3H), 8.64 (d,
J = 8.22 Hz, 1H), 8.89 (d, J = 9.43 Hz, 1H), 9.10 (s, 1H). IR (KBr pellet):
νC≡O = 2017 cm-1, 1889 cm–1. MLCT band (CH2Cl2) [ε (M–1 cm–1)]:
467 nm (2657). ESI-MS analysis (positive mode) m/z = 549.1 [M –
Br]+.
fac-[Mn(CO)3L2Br] L2 = (Dipyrido[3,2-a:2′,3′-c]phenazine) (39):
The L2 ligand was prepared according to literature.[14] 30 mg
(0.11 mmol) of L2 and 91 mg (0.33 mmol, 3 equiv.) of [Mn(CO)5Br]
were placed in 50 mL of CH2Cl2. The solution was stirred overnight
at room temperature while kept in the dark. A pure yellow solid
was collected by filtration, washed with cold (0° C) solvent and
dried under vacuum. Yield: 53 mg (32 %). Elemental Anal. Calcd. for
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C21H10BrMnN4O3: C 50.33 %, H 2.01 %, N 11.18 %. Found: C 50.79 %,
H 2.16 %, N 10.97 %. 1H-NMR (400 MHz, CDCl3): δ (ppm) = 8.04 (s,
4H), 8.44 (s, 2H), 9.64 (bs, 2H), 9.76 (d, J = 6.4 Hz, 2H). IR (KBr pellet):
νC≡O = 2022 cm–1, 1917 cm–1. MLCT band (CH2Cl2) [ε (M–1 cm–1)]:
430 nm (4215). ESI-MS analysis (positive mode) m/z = 421.1 [M –
Br]+.
fac-[Mn(CO)3L2Br] L2 = (6,6′-Diphenyl-4,4′-bipyrimidine) (41):
The L2 ligand was prepared according to reference[32]. 0.112 g
(0.36 mmol) of L2 and 300 mg (1.09 mmol, 3 equiv.) of [Mn(CO)5Br]
were added to 50 mL of CH2Cl2. The solution was stirred overnight
at room temperature while kept in the dark. A pure dark red solid
was collected by filtration, washed with cold (0° C) solvent and
dried under vacuum. Yield: 162 mg (28 %). Elemental Anal. Calcd.
for C23H14BrMnN4O3: C 52.20 %, H 2.67 %, N 10.59 %. Found:
C 51.59 %, H 2.91 %, N 10.44 %. 1H-NMR (400 MHz, [D6]DMSO): δ
(ppm) = 7.71–7.74 (m, 6H), 8.50–8.53 (m, 4H), 9.54 (s, 2H), 9.91 (s,
2H). IR (KBr pellet): νC≡O = 2034 cm–1, 1950 cm–1, 1901 cm–1. MLCT
band (CH2Cl2) [ε (M–1 cm–1)]: 512 nm (4000). ESI-MS analysis (posi-
tive mode) m/z = 449.1 [M – Br]+ and 421.1 [M – Br – CO]+.
fac-[Re(CO)3L2Br] L2 = (6,6′-Diphenyl-4,4′-bipyrimidine) (42): The
L2 ligand was prepared according to literature.[32] The following re-
action was carried out under argon. 138 mg (0.18 mmol) of [Et4N]2
fac-[Re(CO)3Br3] were dissolved in 10 mL of CH2Cl2. Then, 56 mg
(0.18 mmol, 1 equiv.) of L2 were added and the reaction mixture
stirred at room temperature for 2 h. After this time a red solid had
formed. This precipitate was collected by filtration, washed with
cold (0° C) solvent and dried under vacuum. Yield: 56 mg (47 %).
Elemental Anal. Calcd. for C23H14BrN4O3Re: C 41.82 %, H 2.14 %, N
8.48 %. Found: C 42.12 %, H 2.62 %, N 8.09 %. 1H-NMR (400 MHz,
CD2Cl2): δ (ppm) = 7.65–7.71 (m, 6H), 8.33 (m, 4H), 8.68 (s, 2H), 9.73
(s, 2H). IR (KBr pellet): νC≡O = 2016 cm–1, 1885 cm–1. MLCT band
(CH2Cl2) [ε (M–1 cm–1)]: 467 nm (4740). ESI-MS analysis (positive
mode) m/z = 581.1 [M – Br]+.
fac-[Mn(CO)3L2Br] L2 = (2,3-Di(pyridin-2-yl)quinoxaline) (43):
The L2 ligand was prepared according to literature.[33] 28 mg
(0.1 mmol) of L2 and 54 mg (0.2 mmol, 2 equiv.) of [Mn(CO)5Br]
were dissolved in 15 mL of CH2Cl2. The solution was stirred at reflux
for 12 h while kept in the dark. After this time a dark violet com-
pound was filtered from solution, washed with cold (0° C) solvent
and dried under vacuum. Yield: 40 mg (28 %). Elemental Anal. Calcd.
for C24H12Br2Mn2N4O6: C 39.92 %, H 1.68 %, N 7.76 %. Found: C
39.18 %, H 1.76 %, N 7.67 %. 1H-NMR (400 MHz, CD2Cl2): δ (ppm) =
7.56 (t, J = 5.70 Hz, 2H), 7.87 (t, J = 8.07 Hz 2H), 8.15 (t, J = 5.31 Hz,
2H), 8.34 (d, J = 7.35 Hz, 2H), 8.79 (d, J = 4.53 Hz, 2H), 9.35 (d, J =
4.15 Hz, 2H). IR (KBr pellet): νC≡O = 2019 cm–1, 1909 cm–1. MLCT
band (CH2Cl2) [ε (M–1 cm–1)]: 573 nm (3135). ESI-MS analysis (posi-
tive mode) m/z = 640.8 [M – Br]+.
fac-[Re(CO)3L2Br] L2 = (2,3-Di(pyridin-2-yl)quinoxaline) (44): The
L2 ligand was prepared according to literature.[33] The following re-
action was carried out under argon. 153 mg (0.2 mmol) of [Et4N]2
fac-[Re(CO)3Br3] were dissolved in 40 mL of CH2Cl2. Then, 28 mg
(0.1 mmol, 0.5 equiv.) of L2 were added and the reaction mixture
was stirred at reflux overnight. After hot filtration, the dark brown
solid was dried and recrystallized from an acetone/ether mixture.
Yield: 76 mg (39 %). Elemental Anal. Calcd. for C24H12Br2N4O6Re2:
C 29.28 %, H 1.23 %, N 5.69 %. Found: C 31.08 %, H 1.75 %, N
5.44 %. 1H-NMR (400 MHz, CD2Cl2): δ (ppm) = 7.61 (t, J = 6.60 Hz,
2H), 7.95 (dt, J = 8.00 Hz, 2H), 8.19–8.22 (m, 2H), 8.54 (d, J = 8.3 Hz,
2H), 8.72–8.75 (m, 2H), 9.19 (d, J = 5.42 Hz, 2H). IR (KBr pellet): νC≡O =
2036 cm–1, 1895 cm–1. MLCT band (CH2Cl2) [ε (M–1 cm–1)]: 543 nm
(3700). ESI-MS analysis (positive mode) m/z = 903.0 [M – Br]+. Single
crystals suitable for X-ray diffraction analysis were grown by slow
evaporation of an acetone solution of 44.
fac-[Re(CO)3L2Br] L2 = (5H-Cyclopenta[1,2-b:5,4-b′]dipyridin-5-
one) (46): The L2 ligand and complex 46 were prepared following
the procedure described in literature[20] for the Mn complex with
small variations. Briefly: a total of 84 mg (0.11 mmol) of [Et4N]2 fac-
[Re(CO)3Br3] was dissolved in 5 mL of CH2Cl2. Then, 20 mg
(0.1 mmol, 0.9 equiv.) of L2 in 10 mL of CH2Cl2 were added dropwise
under nitrogen. The reaction mixture was then stirred under nitro-
gen at room temperature overnight. At the end of the reaction,
pentane was carefully layered on top of the yellow solution and the
mixture was allowed to stand until crystals of 46 appeared. These
were then filtered, dried and analyzed. Yield: 32 mg (54 %). Elemen-
tal Anal. Calcd. for C14H6BrN2O4Re: C 31.59 %, H 1.14 %, N 5.26 %.
Found: C 31.57 %, H 1.15 %, N 5.40 %. 1H-NMR (400 MHz, CDCl3): δ
(ppm) = 7.53–7.56 (m, 2H), 8.07–8.10 (m, 2H), 8.71–8.74 (m, 2H).
IR (KBr pellet): νC≡O = 2017 cm–1, 1889 cm–1. MLCT band (CH2Cl2)
[ε (M–1 cm–1)]: 400 nm (2820). ESI-MS analysis (positive mode)
m/z = 344.9 [M – Br]+. Single crystals suitable for X-ray diffraction
analysis were grown by slow diffusion of pentane into a CH2Cl2
solution of 46.
Synthesis of 6-Methyl-4,4′-bis(trifluoromethyl)-2,2′-bipyridine,
L2 of 47 and 48: 2-Chloro-6-methyl-4-(trifluoromethyl)pyridine
(400 mg, 2.04 mmol, 1 equiv.), 2-tributylstannyl-4-(trifluoro-
methyl)pyridine[34] (1.03 g, 2.35 mmol, 1.13 equiv.) and Pd(PPh3)4
(118 mg, 0.1 mmol, 0.05 equiv.) were mixed in 35 mL of anhydrous
toluene under argon and refluxed for 24 h. The crude mixture was
concentrated under reduced pressure and dissolved in 20 mL HClaq.
6 M. The aqueous phase was washed with 10 mL of ethyl acetate,
then cooled to 0 °C, and neutralized with NH4OH. The product was
extracted from the aqueous solution with ethyl acetate (3 × 20 mL)
and the combined organic phases were washed with Brine. The
solvent was removed under rotary evaporation and the resulted
yellow oil was used without further purification. Yield: 587 mg
(94 %). NMR: 1H-NMR (400 MHz, CD2Cl2): δ (ppm) = 8.88 (d, J =
5.13 Hz, 1H), 8.75 (s, 1H), 8.53 (s, 1H), 7.59–7.57 (m, 1H), 7.46 (s, 1H),
2.72 (s, 3H). ESI-MS analysis (positive mode) m/z = 329.1 [M + Na]+.
fac-[Mn(CO)3L2Br] L2 = (6-Methyl-4,4′-bis(trifluoromethyl)-2,2′-
bipyridine) (47): The complex was obtained by a modification of
a published procedure.[35] 34 mg (0.13 mmol, 1.5eq) of Mn(CO)5Br
and 26 mg (0.08 mmol, 1 equiv.) of L2 were refluxed in dry diethyl
ether (10 mL) overnight under argon atmosphere while kept in the
dark. The solvent was removed under reduced pressure and the
pure product was obtained through chromatography column on
silica-gel with CH2Cl2 as eluent. Yield: 39 mg (94 %). Elemental Anal.
Calcd. for C16H8BrF6MnN2O3: C 36.60 %, H 1.54 %, N 5.34 %. Found:
C 35.83 %, H 1.96 %, N 5.72 %. 1H-NMR (400 MHz, CD2Cl2):
δ (ppm) = 9.53 (d, J = 5.75 Hz, 1H), 8.38 (s, 1H), 8.25 (s, 1H), 7.80 (d,
J = 5.75 Hz, 1H), 7.74 (s, 1H), 3.26 (s, 3H). IR (KBr pellet): νC≡O =
2026 cm–1, 1916 cm–1. MLCT band (CH2Cl2) [ε (M–1 cm–1)]: 463 nm
(2710). ESI-MS analysis (positive mode) m/z = 445.3 [M – Br]+.
fac-[Re(CO)3L2Br] L2 = (6-Methyl-4,4′-bis(trifluoromethyl)-2,2′-
bipyridine) (48): The compound was obtained by a modification
of a published procedure.[36] To a solution of 132 mg (0.18 mmol,
1.1eq) of [Et4N]2 fac-[Re(CO)3Br3] in methanol (10 mL) was added
dropwise L2 (50 mg, 0.16 mmol, 1eq) dissolved in 2 mL of methanol.
The reaction mixture was stirred overnight at 50 °C. At the end of
the reaction the solution was filtered and the solvent was removed
under reduced pressure. The crude was purified through chroma-
tography column on SiO2 with CH2Cl2 as eluent. Yield: 84 mg (80 %).
Elemental Anal. Calcd. for C16H8BrF6N2O3Re: C 29.28 %, H 1.23 %,
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N 4.27 %. Found: C 30.01 %, H 1.57 %, N 4.55 %. 1H-NMR (400 MHz,
CD2Cl2): δ (ppm) = 9.35 (d, J = 5.77 Hz, 1H), 8.45 (s, 1H), 8.32 (s, 1H),
7.85 (s,1H), 7.81 (d, J = 5.77 Hz, 1H), 3.18 (s, 3H). IR (KBr pellet):
νC≡O = 2018 cm–1, 1889 cm–1. MLCT band (CH2Cl2) [ε (M–1 cm–1)]:
427 nm (3215). ESI-MS analysis (positive mode) m/z = 576.9 [M –
Br]+.
fac-[Mn(CO)3L2Br] L2 = (4-Methoxy-6-methyl-2,2′-bipyridine)
(49): The L2 ligand was prepared following the procedure described
in literature.[37] The complex was obtained by a modification of a
published procedure.[35] 34 mg (0.13 mmol, 1.5eq) of Mn(CO)5Br
and 16.5 mg (0.08 mmol, 1 equiv.) of L2 were refluxed in dry diethyl
ether (10 mL) for 4 h under argon atmosphere, until an orange
precipitate was formed. The compound was filtered and used with-
out further purification. Yield: 29 mg (87 %). Elemental Anal. Calcd.
for C15H12BrMnN2O4: C 42.99 %, H 2.82 %, N 6.68 %. Found:
C 43.22 %, H 2.93 %, N 6.21 %. 1H-NMR (400 MHz, CD2Cl2):
δ (ppm) = 9.27 (d, J = 5.13 Hz, 1H), 8.08–7.97 (m, 2H), 7.52–7.49 (m,
2H), 6.97 (s,, 1H), 3.98 (s, 3H), 3.06 (s, 3H). IR (KBr pellet): νC≡O =
2015 cm–1, 1905 cm–1. MLCT band (CH2Cl2) [ε (M–1 cm–1)]: 407 nm
(2931). ESI-MS analysis (positive mode) m/z = 339.0 [M – Br]+.
fac-[Re(CO)3L2Br] L2 = (4-Methoxy-6-methyl-2,2′-bipyridine)
(50): The complex was synthesized following the same procedure
reported for complex 49.[36] 92 mg (0.12 mmol, 1.2eq) of [Et4N]2
fac-[Re(CO)3Br3] in 10 mL of methanol and 20 mg of L2 (0.1 mmol,
1eq) in 2 mL of methanol. Yield: 47 mg (85 %). Elemental Anal.
Calcd. for C15H12BrN2O4Re: C 32.73 %, H 2.20 %, N 5.09 %. Found:
C 32.65 %, H 2.28 %, N 4.99 %. 1H-NMR (400 MHz, CD2Cl2): δ
(ppm) = 9.09–9.07 (m, 1H) 8.15–8.13 (m, 1H), 8.08–8.03 (m, 1H), 7.56
(d, J = 2.70 Hz, 1H), 7.54–7.50 (m, 1H), 7.03 (d, J = 2.70, Hz, 1H), 4.00
(s, 3H), 2.99 (s, 3H). IR (KBr pellet): νC≡O = 2015 cm–1, 1860 cm–1.
MLCT band (CH2Cl2) [ε (M–1 cm–1)]: 373 nm (3476). ESI-MS analysis
(positive mode) m/z = 471.0 [M – Br]+.
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